264 related articles for article (PubMed ID: 33622214)
1. Ligustrazine Suppresses Platelet-Derived Growth Factor-BB-Induced Pulmonary Artery Smooth Muscle Cell Proliferation and Inflammation by Regulating the PI3K/AKT Signaling Pathway.
Huang H; Kong L; Luan S; Qi C; Wu F
Am J Chin Med; 2021; 49(2):437-459. PubMed ID: 33622214
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
[TBL] [Abstract][Full Text] [Related]
3. Silencing EIF3A ameliorates pulmonary arterial hypertension through HDAC1 and PTEN/PI3K/AKT pathway in vitro and in vivo.
Yang HT; Wang G; Zhu PC; Xiao ZY
Exp Cell Res; 2023 May; 426(1):113555. PubMed ID: 36921705
[TBL] [Abstract][Full Text] [Related]
4. A modified Fangji Huangqi decoction ameliorates pulmonary artery hypertension via phosphatidylinositide 3-kinases/protein kinase B-mediated regulation of proliferation and apoptosis of smooth muscle cells in vitro and in vivo.
Xue Z; Zhou M; Liu Y; Qin H; Li Y; Zhu Y; Yang J
J Ethnopharmacol; 2023 Oct; 314():116544. PubMed ID: 37088239
[TBL] [Abstract][Full Text] [Related]
5. Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats.
Cao YY; Ba HX; Li Y; Tang SY; Luo ZQ; Li XH
Life Sci; 2020 Jun; 250():117548. PubMed ID: 32173312
[TBL] [Abstract][Full Text] [Related]
6. Nobiletin attenuates monocrotaline-induced pulmonary arterial hypertension through PI3K/Akt/STAT3 pathway.
Yin Q; Wang S; Yang J; Fan C; Yu Y; Li J; Mei F; Zhang S; Xi R; Zhang X
J Pharm Pharmacol; 2023 Aug; 75(8):1100-1110. PubMed ID: 37158759
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling.
Zhang S; Wang J; Qi X; Tao X; Xie W; Wan J; Shen YH; Zhai Z
Exp Cell Res; 2021 Jan; 398(1):112392. PubMed ID: 33227315
[TBL] [Abstract][Full Text] [Related]
8. Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension.
Yamamura A; Fujiwara M; Kawade A; Amano T; Hossain A; Nayeem MJ; Kondo R; Suzuki Y; Inoue Y; Hayashi H; Suzuki S; Sato M; Yamamura H
Eur J Pharmacol; 2024 Jun; 973():176564. PubMed ID: 38614383
[TBL] [Abstract][Full Text] [Related]
9. The novel roles of YULINK in the migration, proliferation and glycolysis of pulmonary arterial smooth muscle cells: implications for pulmonary arterial hypertension.
Wu YC; Wang WT; Yang MC; Su YT; Yeh JL; Hsu JH; Wu JR
Biol Res; 2023 Dec; 56(1):66. PubMed ID: 38057829
[TBL] [Abstract][Full Text] [Related]
10. Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation.
Zhang Y; Cui Y; Deng W; Wang H; Qin W; Huang C; Li C; Zhang J; Guo Y; Wu D; Guo H
Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):362-370. PubMed ID: 27873355
[TBL] [Abstract][Full Text] [Related]
11. Stox1 induced the proliferation and cell cycle arrest in pulmonary artery smooth muscle cells via AKT signaling pathway.
Xu Y; Sun Z; Wang Q; Wang T; Liu Y; Yu F
Vascul Pharmacol; 2019 Sep; 120():106568. PubMed ID: 31207359
[TBL] [Abstract][Full Text] [Related]
12. Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension.
Chen X; Yu X; Lian G; Tang H; Yan Y; Gao G; Huang B; Luo L; Xie L
Biomed Pharmacother; 2024 May; 174():116505. PubMed ID: 38574614
[TBL] [Abstract][Full Text] [Related]
13. Formononetin attenuates monocrotaline‑induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats.
Cai C; Xiang Y; Wu Y; Zhu N; Zhao H; Xu J; Lin W; Zeng C
Mol Med Rep; 2019 Dec; 20(6):4984-4992. PubMed ID: 31702810
[TBL] [Abstract][Full Text] [Related]
14. 3-Bromopyruvate ameliorates pulmonary arterial hypertension by improving mitochondrial metabolism.
Guo Y; Liu X; Zhang Y; Qiu H; Ouyang F; He Y
Life Sci; 2020 Sep; 256():118009. PubMed ID: 32603819
[TBL] [Abstract][Full Text] [Related]
15. Dacomitinib, a new pan-EGFR inhibitor, is effective in attenuating pulmonary vascular remodeling and pulmonary hypertension.
Yu X; Zhao X; Zhang J; Li Y; Sheng P; Ma C; Zhang L; Hao X; Zheng X; Xing Y; Qiao H; Qu L; Zhu D
Eur J Pharmacol; 2019 May; 850():97-108. PubMed ID: 30753867
[TBL] [Abstract][Full Text] [Related]
16. PDGF/MEK/ERK axis represses Ca
Deng L; Chen J; Wang T; Chen B; Yang L; Liao J; Chen Y; Wang J; Tang H; Yi J; Kang K; Li L; Gou D
Am J Physiol Cell Physiol; 2021 Jan; 320(1):C66-C79. PubMed ID: 32966125
[TBL] [Abstract][Full Text] [Related]
17. PDGF Promotes the Warburg Effect in Pulmonary Arterial Smooth Muscle Cells via Activation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway.
Xiao Y; Peng H; Hong C; Chen Z; Deng X; Wang A; Yang F; Yang L; Chen C; Qin X
Cell Physiol Biochem; 2017; 42(4):1603-1613. PubMed ID: 28738389
[TBL] [Abstract][Full Text] [Related]
18. Icotinib Attenuates Monocrotaline-Induced Pulmonary Hypertension by Preventing Pulmonary Arterial Smooth Muscle Cell Dysfunction.
Peng LY; Yu M; Yang MX; Liu P; Zhou H; Huang W; Kong H; Xie WP
Am J Hypertens; 2020 Aug; 33(8):775-783. PubMed ID: 32301965
[TBL] [Abstract][Full Text] [Related]
19. Isorhynchophylline protects against pulmonary arterial hypertension and suppresses PASMCs proliferation.
Guo H; Zhang X; Cui Y; Deng W; Xu D; Han H; Wang H; Chen Y; Li Y; Wu D
Biochem Biophys Res Commun; 2014 Jul; 450(1):729-34. PubMed ID: 24950404
[TBL] [Abstract][Full Text] [Related]
20. Ligustrazine prevents basilar artery remodeling in two-kidney-two-clip renovascular hypertension rats via suppressing PI3K/Akt signaling.
Zhang B; Zhang Y; Deng F; Fang S
Microvasc Res; 2020 Mar; 128():103938. PubMed ID: 31682800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
